Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus

Characterization of a potent and highly unusual minimally enhancing antibody directed against dengue virus

Dengue virus is a major pathogen and severe infections can lead to life threatening dengue hemorrhagic fever (DHF). Dengue exists as four serotypes and DHF is often associated with secondary heterologous infections. Antibody dependent enhancement (ADE) may drive higher virus loads in these secondary...

Full description

Bibliographic Details
Main Authors:	Renner, M, Flanagan, A, Dejnirattisai, W, Puttikhunt, C, Kasinrerk, W, Supasa, P, Wongwiwat, W, Chawansuntati, K, Duangchinda, T, Cowper, A, Midgley, C, Malasit, P, Huiskonen, J, Mongkolsapaya, J, Screaton, G, Grimes, J
Format:	Journal article
Published:	Springer Nature 2018

Similar Items

Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.
by: Midgley, C, et al.
Published: (2012)

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.
by: Dejnirattisai, W, et al.
Published: (2014)

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
by: Dejnirattisai, W, et al.
Published: (2014)

An in-depth analysis of original antigenic sin in dengue virus infection
by: Midgley, C, et al.
Published: (2010)

An in-depth analysis of original antigenic sin in dengue virus infection
by: Midgley, C, et al.
Published: (2011)

An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection (vol 85, pg 410, 2011)
by: Midgley, C, et al.
Published: (2011)

An in-depth analysis of original antigenic sin in dengue virus infection.
by: Midgley, C, et al.
Published: (2011)

Potent neutralizing human monoclonal antibodies preferentially target mature dengue virus particles: implication for novel strategy of dengue vaccine
by: Tsai, W, et al.
Published: (2018)

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
by: Mongkolsapaya, J, et al.
Published: (2003)

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever.
by: Mongkolsapaya, J, et al.
Published: (2003)

Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection
by: Fernandez, E, et al.
Published: (2017)

T cell responses in dengue hemorrhagic fever: are cross-reactive T cells suboptimal?
by: Mongkolsapaya, J, et al.
Published: (2006)

Germline bias dictates cross-serotype reactivity in a common dengue-virus-specific CD8+ T cell response
by: Culshaw, A, et al.
Published: (2017)

Humidity control as a strategy for lattice optimization applied to crystals of HLA-A*1101 complexed with variant peptides from dengue virus.
by: Chotiyarnwong, P, et al.
Published: (2007)

Longitudinal analysis of antibody cross-neutralization following Zika and dengue virus infection in Asia and the Americas
by: Montoya, M, et al.
Published: (2018)

A protective Zika virus E-dimer-based subunit vaccine engineered to abrogate antibody-dependent enhancement of dengue infection
by: Campos, JL, et al.
Published: (2019)

Invariant NKT cell response to dengue virus infection in human.
by: Ponpan Matangkasombut, et al.
Published: (2014-06-01)

Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
by: Alexander Rouvinski, et al.
Published: (2017-05-01)

Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E.
by: Panisadee Avirutnan, et al.
Published: (2007-11-01)

The epitope arrangement on flavivirus particles contributes to Mab C10’s extraordinary neutralization breadth across Zika and dengue viruses
by: Sharma, A, et al.
Published: (2021)

Which dengue vaccine approach is the most promising, and should we be concerned about enhanced disease after vaccination? The challenges of a dengue vaccine
by: Screaton, G, et al.
Published: (2018)

Therapeutic and protective efficacy of a dengue antibody against Zika infection in rhesus monkeys
by: Abbink, P, et al.
Published: (2018)

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
by: Dejnirattisai, W, et al.
Published: (2021)

TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL.
by: Screaton, G, et al.
Published: (1997)

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees
by: Nutalai, R, et al.
Published: (2022)

Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
by: Poonsook Keelapang, et al.
Published: (2023-08-01)

Lymphocyte inhibitor of TRAIL (TNF-related apoptosis-inducing ligand): a new receptor protecting lymphocytes from the death ligand TRAIL.
by: Mongkolsapaya, J, et al.
Published: (1998)

Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus
by: Leyrat, C, et al.
Published: (2014)

Drastic changes in conformational dynamics of the antiterminator M2-1 regulate transcription efficiency in Pneumovirinae
by: Leyrat, C, et al.
Published: (2014)

Structure and self-assembly of the calcium binding matrix protein of human metapneumovirus.
by: Leyrat, C, et al.
Published: (2014)

Differential critical residues on the overlapped region of the non-structural protein-1 recognized by flavivirus and dengue virus cross-reactive monoclonal antibodies
by: Prasit Luangaram, et al.
Published: (2022-12-01)

Evolution of neurovirulent Zika virus
by: Screaton, G, et al.
Published: (2017)

Recent advances in understanding dengue [version 1; referees: 3 approved]
by: Sophie Yacoub, et al.
Published: (2016-01-01)

Structural flexibility and ligand-binding characteristics of the macrophage dengue virus receptor CLEC5A
by: Watson, A, et al.
Published: (2011)

Structural flexibility of the macrophage dengue virus receptor CLEC5A: implications for ligand binding and signaling.
by: Watson, A, et al.
Published: (2011)

High performance dengue virus antigen-based serotyping-NS1-ELISA (plus): A simple alternative approach to identify dengue virus serotypes in acute dengue specimens.
by: Tanapan Prommool, et al.
Published: (2021-02-01)

Dengue and Zika virus cross-reactive human monoclonal antibodies protect against Spondweni virus infection and pathogenesis in mice
by: Salazar, V, et al.
Published: (2019)

Prediction, prevention, and mechanism of early (anaphylactic) antivenom reactions in victims of snake bites.
by: Malasit, P, et al.
Published: (1986)

Sensing of immature particles produced by dengue virus infected cells induces an antiviral response by plasmacytoid dendritic cells.
by: Elodie Décembre, et al.
Published: (2014-10-01)

The immunology of Zika virus
by: Culshaw, A, et al.
Published: (2018)